Closed-loop system for adults with type 2 diabetes
Part of Hormones & metabolism clinical trials.
This trial tests a 'closed-loop' system that automatically adjusts insulin delivery for people with type 2 diabetes. If you already use insulin and certain diabetes medications, this study could help see if a smart insulin pump improves blood sugar control.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 or older.
- You have had type 2 diabetes for at least 1 year.
- You are currently taking (or have been offered) an SGLT2 inhibitor or a GLP-1 receptor agonist.
- You have been using insulin for at least 6 months.
- Your average blood sugar (HbA1c) is less than 15% (140 mmol/mol).
- You are willing to wear the study devices and follow the study plan.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a special type of insulin delivery system (closed-loop) can help people with type 2 diabetes and chronic kidney disease. You'll wear a continuous glucose monitor and insulin pump, and researchers will track how your kidneys respond over time.
This trial compares your current insulin pump therapy with a fully automated closed-loop system (artificial pancreas) that adjusts insulin using a smartphone algorithm. It aims to see which method works better for managing blood sugar levels in people with type 2 diabetes.
This study tests whether a treatment can help your pancreas make more insulin and possibly put your type 2 diabetes into remission. It is for people diagnosed with type 2 diabetes in the last 5 years who are already on diabetes medication.
This trial tests a hybrid closed-loop system that automatically adjusts insulin delivery. It may help you manage your blood sugar more easily if you currently give yourself daily insulin shots.
This study tests a smart insulin pump system that adjusts automatically during exercise. It aims to make managing blood sugar easier and safer.
This study tests a new automated insulin pump system (Omnipod) that adjusts insulin doses on its own throughout the day for people with type 2 diabetes. The goal is to see if it helps keep blood sugar levels more stable while reducing the burden of manual insulin management.
Hear when a new Type 2 Diabetes Treated With Insulin trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.